Skip to main content
. 2022 Jul 12;31:e00290. doi: 10.1016/j.plabm.2022.e00290

Fig. 2.

Fig. 2

Plot of anti-SARS-CoV-2 IgG antibodies using an ELISA targeting the S1 domain of the spike protein: capillary blood (Hem-Col ® (no additive) device) against venous blood.

HHS Vulnerability Disclosure